Entering text into the input field will update the search result below

(OTCQB:OXYS) To Present At The SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference At The Ritz In South Beach On Feb. 22, 2016

Feb. 19, 2016 11:09 AM ETOXYS
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

www.smallcapsolutions.com

We can Assist any Publicly Traded Company Gain Greater Exposure Creating Increased Awareness and Liquidity in the Market Place (Retail or Private)

** Contact us for Custom Tailored Plans for Your situation

www.oxysure.com (OXYS)

OxySure Therapeutics, Inc. To Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

FRISCO, TX / ACCESSWIRE / February 19, 2016

Each company will be provided with a 30-minute time slot to present to an audience of investors and industry professionals and company management will also be available for one-on-one meetings with institutional investors.

Conference registration: complimentary for qualified investors and equity research analysts.

In order to register as an attendee of the conference, please click HERE.

http://finance.yahoo.com/news/oxysure-therapeutics-inc-present-seethruequity-130000330.html

Do Keep In Mind this should work out well since OXYS just appointed a Territorial Sales manager in South Florida

FRISCO, TX--(Marketwired - January 28, 2016) - OxySure Therapeutics Appoints Territory Sales Manager in South Florida"The Florida market is tremendous and largely untapped, and with Eddy on board we are confident of an immediate and significant sales impact," Julian Ross added.http://finance.yahoo.com/news/oxysure-therapeutics-oxys-appoints-territory-133000560.html

This makes the 10th Territory now covered. If you remember each Territorial Sales Manager (TSM) has a minimum quota of $500,000/territory.

If each reaches that plateau, that would mean new revenue flow of $5,000,000 Million for 2016.

The future and upcoming year should be very exciting with OxySure anticipated to eclipse & smash previous sales and revenue records. This will be OXYSure's biggest year to date, with a projected $10,000,000 Million in sales/revenue minimum!!

We believe it is a steal at these levels, a most advantageous price for new investors and a great average out down position. A Diamond in the Rough LONG PLAY, with Short Term Gain potential.

Oxysure has now evolved into a complete Therapeutic Solutions company, offering a wide array of products for everyday emergency, and crisis intervention.

Robert E. Kreh

Principal

Small Cap Solutions, LLC

(443) 567-2609

robkreh@smallcapsolutions.com

robkreh@gmail.com

Disclaimer: You are receiving this message because you have recently requested it and/or in the past expressed an interest in or about information and updates concerning the company OxySure, Therapeutics, Inc., and/or other Micro/Small Cap Companies. This profile has been compiled by Small Cap Solutions, LLC based on information believed to be true. This profile is not guaranteed, neither implied, nor in writing, as to the accuracy and completeness of content, and has been prepared for information purposes only. As such, this profile may contain forward reaching statements, as defined in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the statements either expressed or implied herein. Prospective investors are advised to review the Company's periodic filings with the Securities and Exchange Commission - yahoofinance.com or otcmarkets.com Small Cap Solutions, LLC has received 39,179 Shares of Rule 144 Restricted Commom Stock from Oxysure Therapeutics, Inc. for investor relations services rendered. Additional inquiries available by email to admin@smallcapsolutions.com or by mail to 303 Joppa Crossing Ct. (Suite#1) Joppa, Md. 21085. To unsubscribe to this mailing list, please reply "unsubscribe" to this message.

Disclaimer: All Micro/Small Cap Company(ies) profile(s) are/have been compiled by Small Cap Solutions, LLC based on information believed to be true and gathered either from client companies and/or third party('s)/web sites. These profiles are not guaranteed, neither implied, nor in writing, as to the accuracy and completeness of content, and has been prepared for information purposes only. As such, this profile may contain forward reaching statements, as defined in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the statements either expressed or implied herein. Prospective investors are advised to review the Company's periodic filings with the Securities and Exchange Commission or at yahoofinance.com or otcmarkets.com Small Cap Solutions, LLC may receive cash or stock from client companies for investor relations services rendered. Small Cap Solutions, LLC and/or its Principal/Employees are not registered Broker(s)/Broker Dealer(s) with FINRA or the SEC. Small Cap Solutions, LLC does not make any buy/sell recommendations at any time, but may state their opinion on companies, etc. That is not meant to be a recommendation. All information disseminated by Small Cap Solutions, LLC is believed to be true and public. Additional inquiries available by email to admin@smallcapsolutions.com or by mail to 303 Joppa Crossing Ct. (Suite#1) Joppa, Md. 21085. To unsubscribe to this mailing list, please reply "unsubscribe" to this message.

Analyst's Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.